- Home
- TOVX vs ACON Comparison
TOVX vs ACON Comparison
Compare TOVX & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- ACON
- Stock Information
- Founded
- TOVX 2001
- ACON 2008
- Country
- TOVX United States
- ACON United States
- Employees
- TOVX N/A
- ACON N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- TOVX Health Care
- ACON Technology
- Exchange
- TOVX Nasdaq
- ACON Nasdaq
- Market Cap
- TOVX 4.5M
- ACON 4.3M
- IPO Year
- TOVX 2006
- ACON 2022
- Fundamental
- Price
- TOVX $0.41
- ACON $7.72
- Analyst Decision
- TOVX Hold
- ACON Buy
- Analyst Count
- TOVX 1
- ACON 2
- Target Price
- TOVX N/A
- ACON $481.00
- AVG Volume (30 Days)
- TOVX 1.0M
- ACON 8.9K
- Earning Date
- TOVX 11-11-2025
- ACON 08-14-2025
- Dividend Yield
- TOVX N/A
- ACON N/A
- EPS Growth
- TOVX N/A
- ACON N/A
- EPS
- TOVX N/A
- ACON N/A
- Revenue
- TOVX N/A
- ACON $62,948.00
- Revenue This Year
- TOVX N/A
- ACON $145.39
- Revenue Next Year
- TOVX N/A
- ACON $145.45
- P/E Ratio
- TOVX N/A
- ACON N/A
- Revenue Growth
- TOVX N/A
- ACON 16.68
- 52 Week Low
- TOVX $0.37
- ACON $6.20
- 52 Week High
- TOVX $4.29
- ACON $3,499.51
- Technical
- Relative Strength Index (RSI)
- TOVX 46.51
- ACON 64.19
- Support Level
- TOVX $0.38
- ACON $7.00
- Resistance Level
- TOVX $0.45
- ACON $7.35
- Average True Range (ATR)
- TOVX 0.02
- ACON 0.27
- MACD
- TOVX 0.00
- ACON 0.05
- Stochastic Oscillator
- TOVX 44.00
- ACON 99.09
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.